摘要
多数恶性淋巴瘤患者有突变的p53基因过表达,并且实验表明p53基因与恶性淋巴瘤的发生发展有密切关系。因此,以重组腺病毒为载体将正常p53基因导人肿瘤细胞中并使其稳定表达将会对恶性淋巴瘤起到治疗作用。这已经在基础研究中得到了证实。
In majority of malignant lymphoma patients the overexpression of mutant p53 gene can be found, and experiments show that p53 gene and the genesis currence and development of malignant lymphoma are closely related. Thus, normal p53 gene carried by recombinant adenovirus vector into tumor cells and its stable expression will play a theraputic role in the treatment of malignant lymphoma. This has been confirmed by the basic research.
出处
《国际肿瘤学杂志》
CAS
2008年第7期547-549,共3页
Journal of International Oncology
基金
国家自然科学基金资助项目(30471974)